Diamond-Blackfan Anemia: A Patient Guide

Diamond-Blackfan Anemia (DBA) is a rare, genetic condition in which the bone marrow fails to produce enough red blood cells to meet the body’s needs ^[1]. At its core, DBA is a ribosomopathy, meaning the “factories” inside each cell that build proteins are not functioning correctly due to a genetic change ^[2]. While these factories are needed throughout the body, the process of making red blood cells is so demanding that they are often the first and most severely affected, leading to profound anemia that typically appears within the first year of life ^[3][4].

While this guide often addresses the parent of a young child, DBA is a lifelong condition. The recommendations for cancer surveillance and organ monitoring apply equally to adolescents and adults with DBA.

How DBA is Inherited

Many cases of DBA are de novo (new in the child), meaning neither parent carries the genetic change. Families often fear they did something to cause it during pregnancy, but that is not true. In familial cases, the condition has “variable penetrance,” meaning an affected parent might have little to no symptoms. A genetic counselor can help you understand these risks and guide testing for relatives.

The condition exists on a broad spectrum, and no two children experience it in exactly the same way. While most cases present as severe anemia in infancy, some individuals have a milder form that may not be diagnosed until adulthood, or they may only have physical differences without ever becoming severely anemic ^[4][5]. Approximately 30% to 50% of people with DBA are born with physical anomalies, which most commonly affect the thumbs, the structure of the face, or the development of the heart and kidneys ^[6][7]. Understanding your child’s specific presentation helps the medical team tailor a monitoring plan that addresses both their blood counts and their overall physical development.

Managing DBA requires a carefully coordinated strategy focused on maintaining healthy hemoglobin levels. For many infants, the journey begins with regular blood transfusions to provide the oxygen-carrying cells the body cannot make on its own ^[8]. As a child grows, they may transition to a trial of corticosteroids to stimulate their own marrow, or they may continue with transfusions combined with specialized therapy to remove excess iron from their organs ^[9][10]. For some, a Stem Cell Transplant (HSCT) may be considered, as it remains the only way to permanently fix the bone marrow’s production of red blood cells ^[11].

Because the underlying genetic change remains in the body’s other cells, DBA is considered a cancer-predisposition syndrome that requires lifelong vigilance ^[12]. This means that even if the anemia is successfully treated or cured via transplant, systematic monitoring for certain cancers remains a vital part of long-term survivorship ^[13][9]. It is important to know that colorectal cancer screening follows a defined schedule, whereas osteosarcoma has no established screening imaging and is evaluated promptly when symptoms occur. While the diagnosis brings significant changes, a dedicated care team and a proactive approach to monitoring can help your child lead a full and active life.